These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children. Martyn JA; Greenblatt DJ; Hagen J; Hoaglin DC Eur J Clin Pharmacol; 1989; 36(4):361-7. PubMed ID: 2737228 [TBL] [Abstract][Full Text] [Related]
6. Cimetidine kinetics and dynamics in patients with severe liver disease. Villeneuve JP; Fortunet-Fouin H; Arsène D Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322 [TBL] [Abstract][Full Text] [Related]
7. Altered disposition and availability of cimetidine in liver cirrhotic patients. Gugler R; Müller-Liebenau B; Somogyi A Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cimetidine in patients with liver disease. González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163 [TBL] [Abstract][Full Text] [Related]
10. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam. Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051 [TBL] [Abstract][Full Text] [Related]
11. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function. Guay DR; Matzke GR; Bockbrader HN; Dancik J Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of ranitidine after burn injury. Martyn JA; Bishop AL; Oliveri MF Clin Pharmacol Ther; 1992 Apr; 51(4):408-14. PubMed ID: 1563210 [TBL] [Abstract][Full Text] [Related]
13. Cimetidine disposition in obesity. Abernethy DR; Greenblatt DJ; Matlis R; Gugler R Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798 [TBL] [Abstract][Full Text] [Related]
14. Cimetidine and/or antacid for the control of gastric acidity in pediatric burn patients. Martyn JA Crit Care Med; 1985 Jan; 13(1):1-3. PubMed ID: 3965241 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of cimetidine in pediatric duodenal ulcer. Kato S; Watanabe N; Harada Y Clin Ther; 1991; 13(1):118-25. PubMed ID: 2029717 [TBL] [Abstract][Full Text] [Related]
16. Impact of cimetidine on the pharmacokinetics of theophylline. Schwartz JI; Bachmann KA; Bond LW; Mahajan VK Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Somogyi A; Rohner HG; Gugler R Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531 [TBL] [Abstract][Full Text] [Related]
18. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis. Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756 [TBL] [Abstract][Full Text] [Related]
19. Influence of phenobarbital treatment on cimetidine kinetics. Somogyi A; Thielscher S; Gugler R Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis. Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]